EVERSANA’s alliance with Amazon Web Services (AWS) on the application of generative artificial intelligence (GenAI) to the pharma sector has borne its first fruit – a new
EVERSANA has taken another step forwards in its effort to put generative artificial intelligence (GenAI) at the heart of the pharma industry’s processes.
Eversana has acquired pharmaphorum parent Healthware Group in a move that elevates the longstanding partnership between the companies, expands their geographic reach, and
There's a lot of talk about the role that generative artificial intelligence (AI) will have to play in the pharma industry, and a new alliance between Eversana and Amazon
One of the primary barriers to the growth of the digital health category around the world are fragmented, contradictory, or even entirely absent mechanisms for reimburseme
MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio